2018 American Transplant Congress
Redo Kidney Transplant in FSGS
Kidney and Pancreas Transplant Program, MedStar Georgetown Transplant Institute, Washington, DC.
Objective: Analyze risk of graft failure due to recurrent FSGS in patients with prior failed kidney transplants under consideration for a subsequent transplant.Results: We identified…2018 American Transplant Congress
Two Trajectories of Post-DSA eGFR after Kidney Transplant
A clearer understanding of the patterns of glomerular filtration rate (GFR) decline following donor-specific antibody (DSA) development and the factors that might be associated with…2018 American Transplant Congress
Impact of a Steroid Free Immunosuppressive Regimen on Patient and Graft Outcomes in Pancreas Transplant Recipients
Steroids have been an important component of maintenance immunosuppression in solid organ transplant, but their adverse effect profile has led to the development of steroid…2018 American Transplant Congress
Hospital Readmission Patterns in the First Year after Kidney Transplantation: A Twelve-Year, Single-Center Experience
Transplant Surgery, The Ohio State University Wexner Medical Center, Columbus, OH.
Purpose: The majority of studies examining hospital readmissions (HR) after kidney transplantation (KT) focus on 30-day HR rates using multi-institutional data with non-uniform clinical protocols.…2018 American Transplant Congress
Long-Term Outcomes of Primary Kidney Transplant from Expanded Criteria Maastricht Category 3 DCD Donors: A Single-Centre Observational Study
Background. Kidney transplants (KTx) from standard (STD) DCD donors have higher rates of primary non function (PNF) and delayed graft function (DGF) than DBD but…2018 American Transplant Congress
Belatacept Maintenance Immunosuppression Use and Outcomes in the Real-World Clinical Setting Using OPTN/UNOS Kidney Transplant Registry
1Duke University Medical Center, Durham, NC; 2CTI Consulting, Raleigh, NC.
Introduction:Belatacept (BEL) was FDA approved for Kidney Transplantation (KTx) June 2011. It has largely been evaluated in two controlled trials (N Engl J Med 2016;374:333-43).…2018 American Transplant Congress
Outcome of Second Kidney Transplantation According to Previous Pediatric Donor Type: A Retrospective Cohort Analysis
Medicine-Nephrology, UCLA, Los Angeles, CA.
Background: With the prioritization of age ≤ 18 years old at the time of registration on the kidney transplant waiting list in the United States,…2018 American Transplant Congress
Pancreatic Graft Loss after Simultaneous Pancreas Kidney (SPK) Transplant within First 90 Days. Predictors beyond the Surgical Cause. A UNOS/OPTN Data Analysis
Multi-Organ Transplantation Unit, University of Western Ontario, London, ON, Canada.
Background: Data on causal effects of variables to predict the early pancreatic graft loss in first 90 days is limited.Aim: To predict the early pancreatic…2018 American Transplant Congress
Upper Limb Transplantation in the US: An Early Look at OPTN Data
In July 2014, the OPTN assumed responsibility for developing policy for vascularized composite allotransplantation (VCA). This abstract presents initial data collected in upper limb transplantation…2018 American Transplant Congress
C4d Staining and Graft Survival in Renal Transplant Recipients
Nephrology and Transplant, Henry Ford Hospital, Detroit, MI.
Introduction: C4d staining in peritubular capillaries strongly correlates with presence of acute or chronic antibody mediated rejection (AMR). Data on the significance of variable C4d…
- « Previous Page
- 1
- …
- 28
- 29
- 30
- 31
- 32
- …
- 55
- Next Page »